Company profile ETNB

89bio Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 22:25:33.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
89bio expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201946
38
-17.4% QoQ
199
423.7% QoQ
205
3.0% QoQ
2020 59
28.3% YoY -71.2% QoQ
105
176.3% YoY 78.0% QoQ
92
-53.8% YoY -12.4% QoQ
113
-44.9% YoY 22.8% QoQ
2021 60
1.7% YoY -46.9% QoQ
134
27.6% YoY 123.3% QoQ
112
21.7% YoY -16.4% QoQ
97
-14.2% YoY -13.4% QoQ
2022 175
191.7% YoY 80.4% QoQ
102
-23.9% YoY -41.7% QoQ
218
94.6% YoY 113.7% QoQ
300
209.3% YoY 37.6% QoQ
2023 324
85.1% YoY 8.0% QoQ
322
215.7% YoY -0.6% QoQ
355
62.8% YoY 10.2% QoQ
366
22.0% YoY 3.1% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and 89bio search interestLast update: February 08 2024 22:25:32.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:25:34.

The average 5 years interest of 89bio was 13.11 per week.
The last year interest of 89bio compared to the last 5 years has changed by 87.34%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 155.83%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:25:40.

After 39 days of this quarter the interest is at 102.0. Based on that we can calculate that during remaining 52 days it will total up to 238.0.
pegozafermin expected interest is significantly higher compared to previous quarter (+815.4%) and same quarter last year (+11800.0%).

YearQ1Q2Q3Q4
20190
9
inf% QoQ
5
-44.4% QoQ
13
160.0% QoQ
2020 20
inf% YoY 53.8% QoQ
9
0.0% YoY -55.0% QoQ
12
140.0% YoY 33.3% QoQ
5
-61.5% YoY -58.3% QoQ
2021 12
-40.0% YoY 140.0% QoQ
13
44.4% YoY 8.3% QoQ
6
-50.0% YoY -53.8% QoQ
2
-60.0% YoY -66.7% QoQ
2022 5
-58.3% YoY 150.0% QoQ
2
-84.6% YoY -60.0% QoQ
3
-50.0% YoY 50.0% QoQ
5
150.0% YoY 66.7% QoQ
2023 2
-60.0% YoY -60.0% QoQ
19
850.0% YoY 850.0% QoQ
20
566.7% YoY 5.3% QoQ
26
420.0% YoY 30.0% QoQ
2024 102
5000.0% YoY 292.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and pegozafermin search interestLast update: February 08 2024 22:25:40.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:25:41.

The average 5 years interest of pegozafermin was 1.11 per week.
The last year interest of pegozafermin compared to the last 5 years has changed by 189.19%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 379.1%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:25:52.

After 39 days of this quarter the interest is at 109.0. Based on that we can calculate that during remaining 52 days it will total up to 254.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019422
524
24.2% QoQ
557
6.3% QoQ
485
-12.9% QoQ
2020 544
28.9% YoY 12.2% QoQ
312
-40.5% YoY -42.6% QoQ
472
-15.3% YoY 51.3% QoQ
343
-29.3% YoY -27.3% QoQ
2021 467
-14.2% YoY 36.2% QoQ
533
70.8% YoY 14.1% QoQ
570
20.8% YoY 6.9% QoQ
438
27.7% YoY -23.2% QoQ
2022 392
-16.1% YoY -10.5% QoQ
503
-5.6% YoY 28.3% QoQ
460
-19.3% YoY -8.5% QoQ
416
-5.0% YoY -9.6% QoQ
2023 359
-8.4% YoY -13.7% QoQ
497
-1.2% YoY 38.4% QoQ
548
19.1% YoY 10.3% QoQ
404
-2.9% YoY -26.3% QoQ
2024 109
-69.6% YoY -73.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and nonalcoholic steatohepatitis search interestLast update: February 08 2024 22:25:50.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:25:59.

The average 5 years interest of nonalcoholic steatohepatitis was 35.84 per week.
The last year interest of nonalcoholic steatohepatitis compared to the last 5 years has changed by -4.1%.
The interest for nonalcoholic steatohepatitis is seasonal.
The last year interest is quite lower compared to 5 years ago. It has decreased by -20.53%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:26:11.

After 39 days of this quarter the interest is at 129.0. Based on that we can calculate that during remaining 52 days it will total up to 301.0.
severe hypertriglyceridemia expected interest is significantly higher compared to same quarter last year (+189.4%) but similar to previous quarter.

YearQ1Q2Q3Q4
201912
35
191.7% QoQ
38
8.6% QoQ
66
73.7% QoQ
2020 68
466.7% YoY 3.0% QoQ
54
54.3% YoY -20.6% QoQ
41
7.9% YoY -24.1% QoQ
97
47.0% YoY 136.6% QoQ
2021 77
13.2% YoY -20.6% QoQ
228
322.2% YoY 196.1% QoQ
0
-100.0% YoY -100.0% QoQ
50
-48.5% YoY inf% QoQ
2022 45
-41.6% YoY -10.0% QoQ
71
-68.9% YoY 57.8% QoQ
82
inf% YoY 15.5% QoQ
60
20.0% YoY -26.8% QoQ
2023 104
131.1% YoY 73.3% QoQ
78
9.9% YoY -25.0% QoQ
123
50.0% YoY 57.7% QoQ
261
335.0% YoY 112.2% QoQ
2024 129
24.0% YoY -50.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and severe hypertriglyceridemia search interestLast update: February 08 2024 22:26:10.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:26:16.

The average 5 years interest of severe hypertriglyceridemia was 6.59 per week.
The last year interest of severe hypertriglyceridemia compared to the last 5 years has changed by 79.82%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 242.49%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:26:24.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
89bio stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201973
129
76.7% QoQ
70
-45.7% QoQ
224
220.0% QoQ
2020 137
87.7% YoY -38.8% QoQ
68
-47.3% YoY -50.4% QoQ
224
220.0% YoY 229.4% QoQ
70
-68.8% YoY -68.8% QoQ
2021 228
66.4% YoY 225.7% QoQ
278
308.8% YoY 21.9% QoQ
195
-12.9% YoY -29.9% QoQ
136
94.3% YoY -30.3% QoQ
2022 17
-92.5% YoY -87.5% QoQ
200
-28.1% YoY 1076.5% QoQ
219
12.3% YoY 9.5% QoQ
333
144.9% YoY 52.1% QoQ
2023 161
847.1% YoY -51.7% QoQ
242
21.0% YoY 50.3% QoQ
240
9.6% YoY -0.8% QoQ
340
2.1% YoY 41.7% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and 89bio stock search interestLast update: February 08 2024 22:26:24.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:26:25.

The average 5 years interest of 89bio stock was 13.73 per week.
The last year interest of 89bio stock compared to the last 5 years has changed by 26.58%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 61.98%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for 89bio clinical trials to provide analysis

Correlation between past revenue and 89bio clinical trials search interest

There is not enough data for 89bio clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for 89bio clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:26:32.

After 39 days of this quarter the interest is at 117.0. Based on that we can calculate that during remaining 52 days it will total up to 273.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019190
256
34.7% QoQ
149
-41.8% QoQ
168
12.8% QoQ
2020 148
-22.1% YoY -11.9% QoQ
93
-63.7% YoY -37.2% QoQ
208
39.6% YoY 123.7% QoQ
255
51.8% YoY 22.6% QoQ
2021 197
33.1% YoY -22.7% QoQ
234
151.6% YoY 18.8% QoQ
163
-21.6% YoY -30.3% QoQ
214
-16.1% YoY 31.3% QoQ
2022 329
67.0% YoY 53.7% QoQ
141
-39.7% YoY -57.1% QoQ
259
58.9% YoY 83.7% QoQ
306
43.0% YoY 18.1% QoQ
2023 362
10.0% YoY 18.3% QoQ
378
168.1% YoY 4.4% QoQ
356
37.5% YoY -5.8% QoQ
365
19.3% YoY 2.5% QoQ
2024 117
-67.7% YoY -67.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and liver disease treatments search interestLast update: February 08 2024 22:26:32.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:26:34.

The average 5 years interest of liver disease treatments was 18.73 per week.
The last year interest of liver disease treatments compared to the last 5 years has changed by 39.03%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 67.57%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cardio-metabolic disease therapies to provide analysis

Correlation between past revenue and cardio-metabolic disease therapies search interest

There is not enough data for cardio-metabolic disease therapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cardio-metabolic disease therapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for 89bio San Francisco to provide analysis

Correlation between past revenue and 89bio San Francisco search interest

There is not enough data for 89bio San Francisco to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for 89bio San Francisco to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:26:39.

After 39 days of this quarter the interest is at 65.0. Based on that we can calculate that during remaining 52 days it will total up to 152.0.
89bio news expected interest is significantly higher compared to previous quarter (+83.1%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201962
52
-16.1% QoQ
42
-19.2% QoQ
98
133.3% QoQ
2020 145
133.9% YoY 48.0% QoQ
204
292.3% YoY 40.7% QoQ
93
121.4% YoY -54.4% QoQ
115
17.3% YoY 23.7% QoQ
2021 125
-13.8% YoY 8.7% QoQ
90
-55.9% YoY -28.0% QoQ
166
78.5% YoY 84.4% QoQ
0
-100.0% YoY -100.0% QoQ
2022 100
-20.0% YoY inf% QoQ
59
-34.4% YoY -41.0% QoQ
142
-14.5% YoY 140.7% QoQ
111
inf% YoY -21.8% QoQ
2023 163
63.0% YoY 46.8% QoQ
33
-44.1% YoY -79.8% QoQ
48
-66.2% YoY 45.5% QoQ
83
-25.2% YoY 72.9% QoQ
2024 65
-60.1% YoY -21.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and 89bio news search interestLast update: February 08 2024 22:26:38.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:26:40.

The average 5 years interest of 89bio news was 7.65 per week.
The last year interest of 89bio news compared to the last 5 years has changed by -20.78%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 14.56%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ETNB
Earnings date: 2024-03-08 After close
Earnings date: 2024-03-08 After close
Company name: 89bio Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-31T13:47:46Z

Analyst Upgrades
Cantor Fitzgerald Suspends Overweight Rating on 89bio

2025-10-30T06:00:00Z

GlobeNewswire
Roche purchases shares in tender offer for 89bio, Inc

2025-10-16T23:58:00-04:00

PR Newswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders

2025-10-07T11:57:04-04:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - 89bio, Inc. (0001785173) (Subject)

2025-10-03T16:01:19-04:00

SEC
SCHEDULE 13D Form - General Statement of Acquisition of Beneficial Ownership - 89bio, Inc. (0001785173) (Subject)

2025-10-01T16:45:15-04:00

SEC
SC 14D9 Form - Solicitation, recommendation statements - 89bio, Inc. (0001785173) (Subject)

2025-10-01T20:30:00Z

GlobeNewswire
Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash

2025-10-01T16:01:57-04:00

SEC
SC TO-T Form - Tender offer statement by Third Party - 89bio, Inc. (0001785173) (Subject)

2025-09-29T14:38:00-04:00

PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders

2025-09-24T17:15:51-04:00

SEC
SC14D9C Form - Written communication relating to third party tender offer - 89bio, Inc. (0001785173) (Subject)

2025-09-23T17:30:00-04:00

PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 89bio, Inc. (NASDAQ: ETNB)

2025-09-23T14:00:00-04:00

PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, GTLS, PGRE, ETNB on Behalf of Shareholders

2025-09-19T17:25:39Z

Analyst Upgrades
Raymond James Downgrades 89bio to Market Perform

2025-09-19T11:53:08Z

Analyst Upgrades
Wolfe Research Downgrades 89bio to Peer Perform

2025-09-19T11:23:27Z

Analyst Upgrades
HC Wainwright & Co. Downgrades 89bio to Neutral, Announces $14.5 Price Target